Never underestimate what a professional management team can deliver, particularly when they are also significant shareholders with real money in the game.
The last 12 months is littered with the corpses of punters who under estimated this board or were too lazy to investigate and understand the story.
IMO the price appreciation in the last week is nothing compared to what Roth Capital will do when this company lists on the NASDAQ.
MindMed US$1 billion
CARA US$730 million
Compass US$1.4 billion
IHL US$290 million
IHL Price at posting:
38.5¢ Sentiment: Buy Disclosure: Held